MAKERS LABORATORIES LTD.-$

Makers Laboratories Ltd has announced that its Board of Directors will convene on August 7, 2026. The primary agenda for this meeting is to consider and approve the standalone and consolidated unaudited financial results for the first quarter ended June 30, 2026. The trading window for company securities will remain closed from July 1, 2026, until 48 hours after the declaration of these results, extending to August 9, 2026, in compliance with SEBI regulations.

Makers Laboratories Ltd has informed shareholders about the web-link to access its Annual Report for the Financial Year 2025-26. This is in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has sent letters to shareholders whose email addresses are not registered, providing the direct link to the report. The 41st Annual General Meeting (AGM) is scheduled for August 7, 2026, via Video Conferencing. Shareholders are also reminded to update their KYC details, including PAN, address, mobile number, and bank account information, especially those holding physical securities, to ensure continued receipt of payments and services.

Makers Laboratories Ltd. has announced that its 41st Annual General Meeting (AGM) will be held on Friday, August 7, 2026, at 12:30 p.m. The meeting will be conducted through Video Conferencing/Other Audio Visual Means (VC/OAVM). The company has dispatched the notice for the AGM and the Annual Report for the financial year 2025-26 to its shareholders in electronic mode. Physical copies have been dispensed with as per MCA and SEBI circulars. The Annual Report is also available on the company's website. Shareholders have the facility to exercise their voting rights through electronic means (e-voting) provided by NSDL, with remote e-voting commencing on August 3, 2026, and concluding on August 6, 2026.

Makers Laboratories Ltd has released its Annual Report for the financial year ended March 31, 2026. The report highlights a significant drop in Profit After Tax (PAT) to a loss of ₹171.98 Lakhs in FY26, compared to a profit of ₹464.11 Lakhs in FY25. Total income saw a substantial increase to ₹9094.01 Lakhs in FY26 from ₹5386.81 Lakhs in FY25. However, the company reported a loss before tax of ₹201.13 Lakhs in FY26, a reversal from a profit of ₹492.86 Lakhs in the previous year. The Net Worth increased to ₹9443.41 Lakhs in FY26 from ₹5607.54 Lakhs in FY25. The report also lists the Board of Directors, Company Secretary, Auditors, and Registered Office details.

Makers Laboratories Ltd. has announced the closure of its trading window for dealing in the company's securities by insiders. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be effective from July 1, 2026, and will remain shut until 48 hours after the declaration of the company's unaudited financial results for the first quarter ended June 30, 2026. The specific date for the Board meeting to consider these financial results will be communicated to the stock exchange in due course.

Makers Laboratories Ltd. announced its standalone and consolidated financial results for the fiscal year 2025-26. The Board of Directors approved the audited financial results in a meeting held on May 26, 2026. Standalone revenue from operations for FY26 stood at ₹5,034.73 lacs. The audit reports for both standalone and consolidated financial results have an unmodified opinion. The company's board meeting commenced at 11:30 a.m. and concluded at 12:45 p.m.

Makers Laboratories Ltd. announced its standalone and consolidated financial results for the fiscal year 2025-26. The Board of Directors approved the audited financial results in a meeting held on May 26, 2026. Standalone revenue from operations for FY26 stood at ₹5,034.73 Lacs. The audit reports for both standalone and consolidated financial results have an unmodified opinion. The company's primary operating segment is Pharmaceuticals.

Makers Laboratories Ltd has scheduled a Board of Directors meeting on May 26, 2026, to consider and approve the standalone and consolidated audited financial results for the fourth quarter and financial year ended March 31, 2026. The trading window for insiders remains closed from April 1, 2026, until 48 hours after the declaration of the results, i.e., until May 28, 2026.

Makers Laboratories Ltd., a company with its registered office at 54-D, Kandivali Indl. Estate, Kandivali (West), Mumbai - 400 067, has announced the closure of its trading window for insiders. The closure will be effective from 18th April, 2026 and will remain in force until 48 hours after the declaration of the company’s audited financial results for the 4th quarter and financial year ended 31st March, 2026. The date of the Board meeting for consideration of the unaudited financial results has not been specified yet.

Makers Laboratories Ltd. has announced its standalone and consolidated unaudited financial results for the 3rd quarter and nine months ended 31.12.2025. The meeting was held at Kandivli, Mumbai, and the financial results were approved by the Board of Directors. The company operates in the pharmaceuticals segment and has made provisions for employee benefits including actuarial-based gratuity provisions in the financial results.